| Literature DB >> 16626917 |
Gregory T Siwek1, Michael A Pfaller, Philip M Polgreen, Sandra Cobb, Peter Hoth, Margarida Magalheas-Silverman, Daniel J Diekema.
Abstract
We performed a retrospective observational study to examine the incidence of invasive aspergillosis (IA) among allogeneic hematopoietic stem cell transplant (HSCT) recipients, according to whether patients received at least 1 week of voriconazole prophylaxis. We report no cases of IA among 92 HSCT recipients who received voriconazole prophylaxis compared with a 10% (23/223) incidence among those receiving other systemic antifungals for prophylaxis (P < .0005).Entities:
Mesh:
Substances:
Year: 2006 PMID: 16626917 DOI: 10.1016/j.diagmicrobio.2006.01.018
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803